基于网络药理学的桃仁–红花药对治疗深静脉血栓形成机制研究
The Mechanism of the Herb Pair Persicae Semen-Carthami Flos in the Treatment of Deep Vein Thrombosis Based on Network Pharmacology
DOI: 10.12677/acm.2025.15102870, PDF,   
作者: 聂佳慧, 席佳丽, 王娅梅, 彭林娟:黑龙江中医药大学研究生院,黑龙江 哈尔滨;黄克江*:黑龙江中医药大学附属第二医院外科,黑龙江 哈尔滨
关键词: 深静脉血栓形成桃仁–红花网络药理学作用机制Deep Vein Thrombosis Persicae Semen-Carthami Flos Network Pharmacology Mechanism of Action
摘要: 目的:运用网络药理学方法探讨桃仁–红花药对治疗深静脉血栓形成的作用机制。方法:通过TCMSP数据库筛选出桃仁–红花药对的有效成分并对其进行靶点预测;通过OMIM数据库、GeneCards数据库和TTD数据库收集深静脉血栓形成的靶点;运用Cytoscape3.8.0软件构建药物–成分–靶点–疾病网络图;ClueGO插件进行桃仁–红花药对治疗深静脉血栓形成调控生物过程和通路富集分析。结果:获得桃仁–红花药对44个有效成分,217个潜在靶点,深静脉血栓形成261个靶点,GO分析得到1935条功能条目,KEGG分析共得到128条信号通路。结论:桃仁–红花药对的有效成分可能通过参与部分炎性反应通路、AGE-RAGE信号通路等,发挥抗凝、抗炎、保护血管等功能,起到治疗深静脉血栓形成的作用。
Abstract: Objective: To investigate the mechanism of action of the herb pair Persicae Semen-Carthami Flos in the treatment of deep vein thrombosis using network pharmacology. Methods: Active components of the Persicae Semen-Carthami Flos herb pair were screened and their targets predicted via the TCMSP database. Targets related to deep vein thrombosis were collected from the OMIM, GeneCards, and TTD databases. A drug-component-target-disease network diagram was constructed using Cytoscape3.8.0 software. The ClueGO plugin was employed for enrichment analysis of the biological processes and pathways regulated by the Persicae Semen-Carthami Flos herb pair in the treatment of deep vein thrombosis. Results: A total of 44 active components and 217 potential targets of the Persicae Semen-Carthami Flos herb pair were identified, along with 261 targets associated with deep vein thrombosis. GO analysis yielded 1935 functional entries, and KEGG analysis revealed 128 signaling pathways. Conclusion: The active components of the Persicae Semen-Carthami Flos herb pair may exert anticoagulant, anti-inflammatory, and vascular protective effects by participating in certain inflammatory response pathways, the AGE-RAGE signaling pathway, and others, thereby playing a therapeutic role in deep vein thrombosis.
文章引用:聂佳慧, 席佳丽, 王娅梅, 彭林娟, 黄克江. 基于网络药理学的桃仁–红花药对治疗深静脉血栓形成机制研究[J]. 临床医学进展, 2025, 15(10): 1175-1185. https://doi.org/10.12677/acm.2025.15102870

参考文献

[1] 李晓强, 张福先, 王深明. 深静脉血栓形成的诊断和治疗指南(第三版) [J]. 中国血管外科杂志(电子版), 2017, 9(4): 250-257.
[2] 赵传印, 吴清燕. 通络活血汤治疗下肢深静脉血栓形成临床观察[J]. 新中医, 2011, 43(5): 77-78.
[3] 黄彭, 孟祥奇, 吴晨熙, 等. 补阳还五汤防治骨科大手术后深静脉血栓形成的疗效及安全性Meta分析[J]. 上海中医药杂志, 2021, 55(12): 23-30.
[4] 肖署阳, 蔡立民. 中医药防治骨科大手术后深静脉血栓形成的研究进展[J]. 新中医, 2010, 42(3): 101-103.
[5] 李双双, 郭春燕. 桃红四物汤化学成分及药理作用研究进展[J]. 神经药理学报, 2016, 6(4): 42-49.
[6] 王佐梅, 肖洪彬, 李雪莹, 等. 桃红四物汤的药理作用研究进展[J]. 现代中医药, 2021, 41(2): 22-28.
[7] 袁松林. P-选择素及ICAM-1在下肢深静脉血栓形成患者中的表达及其临床价值研究[D]: [硕士学位论文]. 南充: 川北医学院, 2022.
[8] 李达. TNF-α在深静脉血栓形成中的作用及其机制研究[D]: [博士学位论文]. 苏州: 苏州大学, 2020.
[9] Wakefield, T.W., Myers, D.D. and Henke, P.K. (2008) Mechanisms of Venous Thrombosis and Resolution. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 387-391. [Google Scholar] [CrossRef] [PubMed]
[10] 马伟刚. 血清hs-CRP、IL-6和D-D检测对下肢深静脉血栓形成的诊断和疗效评估价值[J]. 河南外科学杂志, 2022, 28(1): 136-138.
[11] 贾新能, 金佳琪, 宣俊毅, 等. 低分子肝素钙对妊娠合并血栓高风险患者凝血功能及白细胞介素-6和肿瘤坏死因子-α水平的影响[J]. 中国妇幼保健, 2022, 37(10): 1775-1778.
[12] 戴艳枝, 王晓华, 刘秋玲, 等. 白细胞介素-1β、白细胞介素-8及肿瘤坏死因子-α与房颤伴凝血功能异常的相关性[J]. 中国当代医药, 2019, 26(23): 4-7.
[13] Mantsounga, C.S., Lee, C., Neverson, J., Sharma, S., Healy, A., Berus, J.M., et al. (2022) Macrophage Il-1β Promotes Arteriogenesis by Autocrine STAT3-and NF-κB-Mediated Transcription of Pro-Angiogenic VEGF-A. Cell Reports, 38, Article ID: 110309. [Google Scholar] [CrossRef] [PubMed]
[14] 王丽, 李杰辉. AGEs-RAGE信号通路与糖尿病难愈合创面[J]. 中国烧伤创疡杂志, 2015, 27(6): 406-409.